Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Ingrid, Glimelius"'
Autor:
Joachim Baech, Tarec Christoffer El‐Galaly, Joshua P. Entrop, Ingrid Glimelius, Daniel Molin, Sissel Johanne Godtfredsen, Michael J. Crowther, Karin E. Smedby, Sandra Eloranta, Caroline E. Dietrich
Publikováno v:
eJHaem, Vol 5, Iss 6, Pp 1190-1200 (2024)
Abstract Introduction Congestive heart failure (CHF) is a known complication after anthracyclines and radiotherapy for classical Hodgkin lymphoma (cHL). Contemporary cHL treatment may be associated with less risk because radiotherapy use and techniqu
Externí odkaz:
https://doaj.org/article/1b7c3bb6089246c9a932aea190c17a9e
Autor:
Ingrid Glimelius, Geffen Kleinstern, Dennis P. Robinson, Larry Mansouri, Klaus Rostgaard, Henrik Hjalgrim, Carsten Utoft Niemann, Mattias Mattsson, Kari G. Rabe, Paul J. Hampel, Sameer A. Parikh, Richard Rosenquist, James R. Cerhan, Susan L. Slager, Karin E. Smedby
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 998-1004 (2024)
Abstract Background Chronic lymphocytic leukemia (CLL) is a heterogeneous disease. Whereas some patients have an indolent disease, others experience an aggressive course and early death. Our aim was to investigate if modifiable and non‐modifiable m
Externí odkaz:
https://doaj.org/article/4d902961c3344a49b8ed9eb4525c3db9
Autor:
Anna Nikkarinen, Ingrid Glimelius
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 820-824 (2024)
Abstract The use of Bruton's tyrosine kinase inhibitors (BTKi) is rapidly increasing for patients with mantle cell lymphoma (MCL). Side effects reported so far are usually manageable. However, here we present two cases of life‐threatening aplastic
Externí odkaz:
https://doaj.org/article/50b4c284d8bc4181b61e6221f4fd7b3c
Autor:
Anna Thor, Helene F.S. Negaard, Anna Grenabo Bergdahl, Bjarte Almås, Signe Melsen Larsen, Per-Olof Lundgren, Axel Gerdtsson, Dag Halvorsen, Berglind Johannsdottir, Anna K. Jansson, Martin Hellström, Rolf Wahlqvist, Carl W. Langberg, Annika Hedlund, Olof Akre, Ingrid Glimelius, Olof Ståhl, Hege Sagstuen Haugnes, Gabriella Cohn-Cedermark, Anders Kjellman, Torgrim Tandstad
Publikováno v:
European Urology Open Science, Vol 65, Iss , Pp 13-19 (2024)
Background and objective: There is an unmet need to avoid long-term morbidity associated with standard cytotoxic treatment for low-volume metastatic seminoma. Our aim was to assess the oncological efficacy and surgical safety of retroperitoneal lymph
Externí odkaz:
https://doaj.org/article/6d777327c33a4d1a9c1d68fb3b8b5aab
Autor:
Karin Ekström Smedby, Sandra Eloranta, Tove Wästerlid, Victor Falini, Urban Jerlström, Fredrik Ellin, Karin Papworth, Johanna Westerberg, Catharina Lewerin, Per-Ola Andersson, Hallgerdur Lind Kristjansdottir, Lena Brandefors, Charlott Mörth, Karin Hallén, Nevzeta Kuric, Amal Abu Sabaa, Björn E. Wahlin, Daniel Molin, Gunilla Enblad, Ann-Sofi Hörstedt, Mats Jerkeman, Ingrid Glimelius
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: The Swedish Lymphoma Register (SLR) was initiated in the year 2000 with the aim to monitor quality of care in diagnostics, treatment and outcome of all lymphomas diagnosed nationally among adults. Here, we present the first sy
Externí odkaz:
https://doaj.org/article/7ee070d713af42f29167468a2f959abb
Autor:
Kossi D. Abalo, Sara Ekberg, Therese M. L. Andersson, Simon Pahnke, Alexandra Albertsson‐Lindblad, Karin E. Smedby, Mats Jerkeman, Ingrid Glimelius
Publikováno v:
HemaSphere, Vol 8, Iss 7, Pp n/a-n/a (2024)
Abstract Advancements in treatments have significantly improved the prognosis for mantle cell lymphoma (MCL), and there is a growing population of survivors with an increased susceptibility to infections. We assessed the incidence of infections by cl
Externí odkaz:
https://doaj.org/article/21cce12d5c1242128c67c1e9b23f2133
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 46, Iss , Pp 100785- (2024)
Background and purpose: The role of radiotherapy (RT) in lymphoma is constantly refined with the advent of novel treatments. However, RT is still an effective treatment and tolerability is high. Therefore, we aimed to describe the use of RT in primar
Externí odkaz:
https://doaj.org/article/86c6266f450540e383cfd01acc150b1f
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
In Mantle Cell Lymphoma (MCL), the role of macrophages within the tumour microenvironment (TME) has recently gained attention due to their impact on prognosis and response to therapy. Despite their low absolute number in MCL tumour tissue, recent fin
Externí odkaz:
https://doaj.org/article/3a7278a0a0e7476d87eafe1a29abce44
Autor:
Joana M. Rodrigues, Peter Hollander, Lina Schmidt, Eirinaios Gkika, Masoud Razmara, Darshan Kumar, Christian Geisler, Kirsten Grønbæk, Christian W. Eskelund, Riikka Räty, Arne Kolstad, Christer Sundström, Ingrid Glimelius, Anna Porwit, Mats Jerkeman, Sara Ek
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
The transcription factor MYC is a well-described oncogene with an important role in lymphomagenesis, but its significance for clinical outcome in mantle cell lymphoma (MCL) remains to be determined. We performed an investigation of the expression of
Externí odkaz:
https://doaj.org/article/39c05dfdcc6f46b984fdbc58d95a8e72
Autor:
Mats Jerkeman, Sara Ekberg, Ingrid Glimelius, Alexandra Albertsson-Lindblad, Joshua P. Entrop, Fredrik Ellin, Kristina Sonnevi, Catharina Lewerin, Lena Brandefors, Karin E. Smedby
Publikováno v:
HemaSphere, Vol 7, Iss 8, p e928 (2023)
Mantle cell lymphoma (MCL) is a B-cell malignancy currently considered incurable. Although some patients obtain prolonged remission after first-line chemoimmunotherapy, many will need several treatment lines. Here, we present a nationwide assessment
Externí odkaz:
https://doaj.org/article/35ed8116516c469c8ec483f8432db57d